Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00433277
NCT00433277UnknownNot Applicable

Autoimmunity in Retinitis Pigmentosa

Semmelweis University2 sites in 1 countryStarted: February 9, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Locations
2
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Clinical diagnosis of retinitis pigmentosa

Exclusion Criteria

  • •Extremely low ERG wave amplitude (less than 8% of normal)

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials

Completed
Not Applicable
The study for diagnosing autoimmune retinopathy using the blood sera from the patientsautoimmune retinopathy
JPRN-UMIN000002449Department of Surgery, Division of Ophthalmology,Kobe University Graduated School of Medicine28
Completed
Not Applicable
Autoimmunity in the Pathogenesis of AFAtrial Fibrillation
NCT03498729Mayo Clinic75
Completed
Not Applicable
Autoimmunity in Neurologic Complications of Celiac DiseaseAtaxia
NCT00692861National Institute of Neurological Disorders and Stroke (NINDS)14
Completed
Not Applicable
Autoimmune Dysregulation in Pigmentary GlaucomaPigmentary GlaucomaPrimary Open Angle GlaucomaCataract
NCT00280345University of Oklahoma23
Completed
Not Applicable
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort StudyInfectionMortalityImmunosuppressionCancerUveitis
NCT00116090National Eye Institute (NEI)6,300